Category: Orthofix International
Covidien CFO Charles Dockendorff plans to retire at the end of 2014, leaving a vacancy in a role he's filled for 25 years.
Covidien (NYSE:COV) said it's searching for a new CFO after Charles Dockendorff announced his plans to retire from the company at the end of 2014.
Dockendorff has been with the company since 1989, serving in a variety of finance-related roles. He was named CFO of Covidien predecessor Tyco Healthcare in 1995, helping lead the company to $10 billion in sales in 2007.
A Virginia podiatrist is convicted of lying to a grand jury about her involvement in a scheme to defraud Medicare by collecting reimbursement for procedures using Orthofix's bone growth stimulator.
InVivo Therapeutics taps its 3rd CFO since August, naming Steven McAllister to replace interim CFO Gregory Perry.
InVivo Therapeutics (OTC:NVIV) is on its 3rd financial chief since August, saying it named Steven McAllister to replace interim CFO Gregory Perry.
Perry stepped down effective Dec. 30 to join an unnamed biotechnology company as its CFO, according to a press release.
Cook Medical rearranges its management, naming Rob Lyles as its new executive vice president.
Cook Medical named Rob Lyles executive vice president, the latest move in a larger management shift at the Indiana medtech maker.
Lyles was formerly vice president of Cook's peripheral intervention division. He has been with the company since 2003 and was named division VP in 2007. Lyles' promotion follows the advancement of Pete Yonkman to president of the Cook Medical. Mark Breedlove, a 19-year veteran of Cook Medical, will succeed Lyles as VP of the peripheral intervention division.
, CareFusion Corp.
, Cook Group Inc.
, Cook Medical
, IDEX Corp.
, Life Technologies Corp.
, Orthofix International
, Stryker Corp.
, Thermo Fisher Scientific
Orthofix gets a non-compliance notification from Nasdaq as the company delays its quarterly earnings report.
Orthofix (NSDQ:OFIX) said it was issued a notification from Nasdaq after not filing its quarterly report on time.
Orthofix chairman Jim Gero steps down and is replaced by private equity player Randy Thurman.
Orthofix (NSDQ:OFIX) chairman Jim Gero stepped down, effective immediately, to be replaced by Randy Thurman.
Gero, a member of the orthopedic medical device company's board since 1998, was named chairman in 2005. He'll continue as a consultant to the board until 2015, according to a press release.
A raft of shareholders sue Orthofix after the medical device company's plan to restate its financials sends share prices down 16% in a day.
Shareholders of Orthofix (NSDQ:OFIX) piled a raft of lawsuits on the medical device company, accusing it of failing to warn investors that would have to restate its financial results going back to 2011.